07/08/2026
The 2026 International Congress on Obesity was held in Mexico City on 15–17 July. Data on the benefits of incretin therapies in both adults and children were presented, as well as a new international joint consensus on nutritional, functional and psychological considerations when using these therapies for weight management.
Findings were also presented on the cardiovascular risks associated with preclinical obesity and with ultra-processed food consumption, as well as the adverse outcomes associated with excessive gestational weight gain, irrespective of pre-pregnancy weight.
In this short report, Pam Brown summarises the highlights from the Congress:
https://eu1.hubs.ly/H0xwH0K0